Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6,912.00
Bid: 6,912.00
Ask: 6,913.00
Change: 54.00 (0.79%)
Spread: 1.00 (0.01%)
Open: 6,927.00
High: 6,927.00
Low: 6,853.00
Yest. Close: 6,858.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

COVAX programme doubles global vaccine supply deals to 2 billion doses

Dec 18 (Reuters) - The COVAX alliance which aims to secure COVID-19 vaccines for the world's most vulnerable people said on Friday it had gained access to nearly 2 billion doses, roughly doubling its supply, with the first deliveries expected in t...

18 Dec 20 13:00

UK PM Johnson says he hopes to avoid another lockdown for England

LONDON, Dec 18 (Reuters) - British Prime Minister Boris Johnson said on Friday he hoped that England would not need to go into a third lockdown after Christmas and follow Wales and Northern Ireland in imposing the measure to stop the growing spre...

18 Dec 20 12:02

UPDATE 1-Oxford says vaccine has good immune response with two-dose regime

(Adds detail, background)LONDON, Dec 17 (Reuters) - Oxford's COVID-19 vaccine candidate has a better immune response when a two full-dose regime is used rather than a full-dose followed by a half-dose booster, the university said on Thursday.The v...

17 Dec 20 16:34

UPDATE 2-Early data show two doses of Oxford/AstraZeneca vaccine provoked good immune response

(Adds context)LONDON, Dec 17 (Reuters) - Oxford University's COVID-19 vaccine candidate has a better immune response when a two full-dose regime is used rather than a full-dose followed by a half-dose booster, the university said on Thursday, citi...

17 Dec 20 16:34

Oxford says vaccine has good immune response with two dose regime

LONDON, Dec 17 (Reuters) - Oxford's COVID-19 vaccine candidate stimulates broad antibody and T cell responses and has the best immune response when a two full-dose regime is used, the university said, citing more detailed early stage trial data.T...

17 Dec 20 16:05

Pfizer has not yet applied for emergency use of vaccine in Brazil, agency says

RIO DE JANEIRO, Dec 17 (Reuters) - Pfizer has not yet applied for emergency use of its COVID-19 vaccine in Brazil, health regulator Anvisa said on Thursday, adding that the company has not yet provided enough data for the vaccine to be used local...

17 Dec 20 15:21

UPDATE 1-Pfizer hits snags registering vaccine for emergency use in Brazil -health minister

(Adds Pfizer)RIO DE JANEIRO, Dec 17 (Reuters) - Pfizer is encountering difficulty in registering its COVID-19 vaccine for emergency use in Brazil due to the level of detail required by the regulator, Health Minister Eduardo Pazuello said on Thurs...

17 Dec 20 15:17

UPDATE 2-Pfizer hits snags registering vaccine for emergency use in Brazil

RIO DE JANEIRO, Dec 17 (Reuters) - Pfizer is encountering difficulty in registering its COVID-19 vaccine for emergency use in Brazil due to the level of detail required by the regulator, Health Minister Eduardo Pazuello said on Thursday.Health re...

17 Dec 20 15:17

UPDATE 3-Brazil, Pfizer spar over onerous COVID-19 vaccine requirements

(Adds Pfizer comments)By Pedro FonsecaRIO DE JANEIRO, Dec 17 (Reuters) - Pfizer is encountering difficulty in registering its COVID-19 vaccine for emergency use in Brazil due to the level of detail required by the regulator, Health Minister Eduard...

17 Dec 20 15:17

Brazil health minister eyes up to 24 mln vaccines by January

RIO DE JANEIRO, Dec 17 (Reuters) - Brazil expects to receive some 24 million COVID-19 vaccines by January, Health Minister Eduardo Pazuello said on Thursday.Pazuello said the expected vaccines in January could be made up of 500,000 Pfizer doses, 9...

17 Dec 20 14:20

Thursday broker round-up

(Sharecast News) - Yellow Cake: Berenberg reiterates buy with a target price of 300p.

17 Dec 20 13:13

UK PM Johnson wishes France's Macron a speedy recovery from COVID-19

LONDON, Dec 17 (Reuters) - British Prime Minister Boris Johnson sent his best wishes to France's Emmanuel Macron on Thursday after the French President tested positive for COVID-19."Sorry to hear my friend @EmmanuelMacron has tested positive for ...

17 Dec 20 10:27

EU to order more Pfizer vaccine after declining earlier offer

* EU to exercise option for up to 100 mln more Pfizer shots* EU declined in July Pfizer offer for 500 mln doses - document* EU has ordered 200 mln doses so far, jab approval due next weekBy Francesco GuarascioBRUSSELS, Dec 17 (Reuters) - The Europe...

17 Dec 20 10:15

UK BROKER RATINGS SUMMARY: BofA Rates Rotork Buy, Weir Underperform

UK BROKER RATINGS SUMMARY: BofA Rates Rotork Buy, Weir Underperform

17 Dec 20 09:48

Nigeria expects to get its first COVID-19 vaccine doses in January

By Felix OnuahABUJA, Dec 16 (Reuters) - Nigeria expects to receive its first doses of a COVID-19 vaccine in January, the country's health minister said on Wednesday, but officials do not yet know which one they will get.Africa's most populous nati...

16 Dec 20 18:55

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.